Logo image of ALPIX.PA

Pixium Vision SA (ALPIX.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALPIX - FR001400JX97 - Common Stock

0.3764 EUR
-0.04 (-10.17%)
Last: 1/30/2024, 7:00:00 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ALPIX. ALPIX was compared to 62 industry peers in the Health Care Equipment & Supplies industry. ALPIX has a bad profitability rating. Also its financial health evaluation is rather negative. ALPIX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALPIX has reported negative net income.
In the past year ALPIX has reported a negative cash flow from operations.
ALPIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALPIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

ALPIX's Return On Assets of -154.03% is on the low side compared to the rest of the industry. ALPIX is outperformed by 98.11% of its industry peers.
Industry RankSector Rank
ROA -154.03%
ROE N/A
ROIC N/A
ROA(3y)-65.25%
ROA(5y)-66.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALPIX.PA Yearly ROA, ROE, ROICALPIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200

1.3 Margins

ALPIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALPIX.PA Yearly Profit, Operating, Gross MarginsALPIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

ALPIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALPIX has more shares outstanding
Compared to 1 year ago, ALPIX has a worse debt to assets ratio.
ALPIX.PA Yearly Shares OutstandingALPIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
ALPIX.PA Yearly Total Debt VS Total AssetsALPIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

ALPIX has an Altman-Z score of -8.48. This is a bad value and indicates that ALPIX is not financially healthy and even has some risk of bankruptcy.
ALPIX has a worse Altman-Z score (-8.48) than 92.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.48
ROIC/WACCN/A
WACC5.07%
ALPIX.PA Yearly LT Debt VS Equity VS FCFALPIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.74 indicates that ALPIX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.74, ALPIX is doing worse than 94.34% of the companies in the same industry.
A Quick Ratio of 0.74 indicates that ALPIX may have some problems paying its short term obligations.
With a Quick ratio value of 0.74, ALPIX is not doing good in the industry: 71.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
ALPIX.PA Yearly Current Assets VS Current LiabilitesALPIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

ALPIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.60%, which is quite impressive.
The Revenue has decreased by -4.23% in the past year.
Measured over the past years, ALPIX shows a decrease in Revenue. The Revenue has been decreasing by -5.07% on average per year.
EPS 1Y (TTM)29.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y3.13%
Revenue growth 5Y-5.07%
Sales Q2Q%-13.46%

3.2 Future

ALPIX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.50% yearly.
The Revenue is expected to decrease by -35.08% on average over the next years. This is quite bad
EPS Next Y55%
EPS Next 2Y24.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y-35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALPIX.PA Yearly Revenue VS EstimatesALPIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALPIX.PA Yearly EPS VS EstimatesALPIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALPIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALPIX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALPIX.PA Price Earnings VS Forward Price EarningsALPIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALPIX.PA Per share dataALPIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as ALPIX's earnings are expected to grow with 24.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.5%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALPIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Pixium Vision SA

EPA:ALPIX (1/30/2024, 7:00:00 PM)

0.3764

-0.04 (-10.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.53M
Revenue(TTM)1.81M
Net Income(TTM)-10.52M
Analysts86.67
Price Target45.9 (12094.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)37.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.99
EYN/A
EPS(NY)-4.63
Fwd EYN/A
FCF(TTM)-2.03
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS0.44
BVpS-1.52
TBVpS-1.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -154.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.25%
ROA(5y)-66.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -8.48
F-Score3
WACC5.07%
ROIC/WACCN/A
Cap/Depr(3y)13%
Cap/Depr(5y)9.22%
Cap/Sales(3y)3.48%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
EPS Next Y55%
EPS Next 2Y24.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y3.13%
Revenue growth 5Y-5.07%
Sales Q2Q%-13.46%
Revenue Next Year-5.17%
Revenue Next 2Y-35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-30.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.82%
OCF growth 3YN/A
OCF growth 5YN/A

Pixium Vision SA / ALPIX.PA FAQ

What is the fundamental rating for ALPIX stock?

ChartMill assigns a fundamental rating of 0 / 10 to ALPIX.PA.


What is the valuation status of Pixium Vision SA (ALPIX.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to Pixium Vision SA (ALPIX.PA). This can be considered as Overvalued.


Can you provide the profitability details for Pixium Vision SA?

Pixium Vision SA (ALPIX.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for Pixium Vision SA?

The Earnings per Share (EPS) of Pixium Vision SA (ALPIX.PA) is expected to grow by 55% in the next year.